Allogene Therapeutics Ownership & Insider Activity

Allogene Therapeutics (ALLO) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 4.2% of shares outstanding. Institutional investors hold 36.8%. Over the past 90 days, insiders made 1 sale worth $63K.

Shares Outstanding

345.491M

Shares Float

312.199M

Insider Shares Owned

14.437M

Insider % Owned

4.2%

Institutional Shares Held

127.208M

Institutional % Held

36.8%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$63K total

Net Activity

Net Selling

Net Value (90d)

-$63K

Allogene Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Aug 21, 2026	Earl Douglas	SVP, GENERAL COUNSEL	SELL	29.697K	$2.12	$63K